Baxter Pharmaceuticals India Pvt LtdAugust 4, 2017

FDA 483 - Baxter Pharmaceuticals India Pvt Ltd - August 04, 2017

FDA 483 for Baxter Pharmaceuticals India Pvt Ltd on August 04, 2017. Product: N/A. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA 483 for Baxter Pharmaceuticals India Pvt Ltd on August 04, 2017. Product: N/A. Access full analysis and detailed observations.

Violation Codes

FD&C Act 801(a)(3)

21 CFR 331(c)

21 U.S.C. 324(a)(4)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Baxter Pharmaceuticals India Pvt Ltd

Inspection Date

August 4, 2017

Product Type

Office

Office of Compliance

ID: 39ff32de-a58e-445e-8df1-f22283913a75

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox